Find a clinical trial

FindClinicalTrial

If you have questions about clinical trials or want help finding the right one for you, contact our:

Patient Engagement Center Phone: 844-552-2734

This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.

Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.

« Previous 12345 Next »
Viewing Page 1 of 8 | Showing Results 1 - 5 of 37

John Wayne Cancer Institute Biospecimen and Research Data Repository

The purpose of this study is to collect clinical data and biological specimens (e.g., blood, tumor,cerebrospinal fluid, urine sample, etc.) from...

Jennifer Linehan, M.D.
  • Disney Family Cancer Center (DFCC)
  • John Wayne Cancer Institute (JWCI)
  • Providence Los Angeles Research Center
  • Providence St. Johns Health Center (PSJHC)

John Wayne Cancer Institute Biospecimen and Research Data Repository

The purpose of this study is to collect clinical data and biological specimens (e.g., blood, tumor,cerebrospinal fluid, urine sample, etc.) from...

Jennifer Linehan, M.D.
  • John Wayne Cancer Institute (JWCI)
  • Providence St. Johns Health Center (PSJHC)

John Wayne Cancer Institute Biospecimen Repository

Jose Esteban, M.D.
  • Disney Family Cancer Center (DFCC)
  • Providence Los Angeles Research Center
  • Providence St. Joseph Medical Center (PSJMC)

SJH 14-095-Alliance A081105- A randomized double blind placebo controlled study of Erlotinib or placebo in patients with completely resected epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) (Alchemist 2)

This randomized phase III trial studies how well erlotinib hydrochloride compared to observation works in treating patients with stage IB-IIIA...

Timothy Byun, M.D.
  • SJH Southern California
  • St. Joseph Hospital of Orange

SJH 14-104-E4512: A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

This randomized phase III trial studies how well crizotinib works and compares it to placebo in treating patients with stage IB-IIIA non-small cell...

Timothy Byun, M.D.
  • SJH Southern California
  • St. Joseph Hospital of Orange
« Previous 12345 Next »
Viewing Page 1 of 8 | Showing Results 1 - 5 of 37